[用于治疗面部血管纤维瘤的0.4%西罗莫司局部制剂] - Suppr | 超能文献

[Topical sirolimus 0.4% formulation for treatment of facial angiofibromas].

作者信息

Cuevas Asencio I, Albornoz López R, Salido Vallejo R, Reyes Malia M

出版信息

Farm Hosp. 2012 Sep-Oct;36(5):433-4. doi: 10.1016/j.farma.2011.09.006. Epub 2012 Jul 31.

DOI:10.1016/j.farma.2011.09.006

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Topical sirolimus 0.4% formulation for treatment of facial angiofibromas].[用于治疗面部血管纤维瘤的0.4%西罗莫司局部制剂]

Farm Hosp. 2012 Sep-Oct;36(5):433-4. doi: 10.1016/j.farma.2011.09.006. Epub 2012 Jul 31.

2

Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis.外用雷帕霉素：治疗结节性硬化症面部血管纤维瘤的新方法。

Arch Dermatol. 2010 Jul;146(7):715-8. doi: 10.1001/archdermatol.2010.125.

3

[Facial angiofibromas associated to tuberous sclerosis treated with topical sirolimus].[外用西罗莫司治疗与结节性硬化症相关的面部血管纤维瘤]

Ugeskr Laeger. 2013 Oct 21;175(43):2569-70.

4

Comparative Effects of Topical 0.2% Sirolimus for Angiofibromas in Adults and Pediatric Patients with Tuberous Sclerosis Complex.成人与结节性硬化症伴发的青少年血管纤维瘤患者中局部使用 0.2%西罗莫司的疗效比较。

Dermatology. 2018;234(1-2):13-22. doi: 10.1159/000489089. Epub 2018 Jun 20.

5

[Topical rapamycin solution to treat multiple facial angiofibromas in a patient with tuberous sclerosis].[外用雷帕霉素溶液治疗结节性硬化症患者的多发性面部血管纤维瘤]

Actas Dermosifiliogr. 2012 Mar;103(2):165-6. doi: 10.1016/j.ad.2011.02.019. Epub 2011 Aug 20.

6

Dramatic improvement of facial angiofibromas in tuberous sclerosis with topical rapamycin: optimizing a treatment protocol.外用雷帕霉素治疗结节性硬化症面部血管纤维瘤疗效显著：优化治疗方案

Arch Dermatol. 2011 Sep;147(9):1116-7. doi: 10.1001/archdermatol.2011.254.

7

Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin.西罗莫司成功治疗结节性硬化症相关的血管纤维瘤。

J Dermatolog Treat. 2012 Feb;23(1):46-8. doi: 10.3109/09546634.2010.489598. Epub 2010 Aug 1.

8

Treatment of facial angiofibromas with topical application of oral rapamycin solution (1mgmL(-1) ) in two patients with tuberous sclerosis.两名结节性硬化症患者局部应用口服雷帕霉素溶液（1mg/mL）治疗面部血管纤维瘤。

Br J Dermatol. 2011 Oct;165(4):922-3. doi: 10.1111/j.1365-2133.2011.10476.x.

9

A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity.局部应用雷帕霉素和他克莫司联合治疗结节性硬化症相关的血管纤维瘤：一项不同疾病严重程度的 9 例日本结节性硬化症患者的初步研究

Br J Dermatol. 2011 Oct;165(4):912-6. doi: 10.1111/j.1365-2133.2011.10471.x.

10

Topical 0.2% rapamycin to treat facial angiofibromas and hypomelanotic macules in tuberous sclerosis.外用0.2%雷帕霉素治疗结节性硬化症的面部血管纤维瘤和色素减退斑。

Actas Dermosifiliogr. 2014 Oct;105(8):802-3. doi: 10.1016/j.ad.2013.09.013. Epub 2013 Dec 17.

引用本文的文献

1

Rapamycin and rapalogs for tuberous sclerosis complex.雷帕霉素及其类似物治疗结节性硬化症。

Cochrane Database Syst Rev. 2023 Jul 11;7(7):CD011272. doi: 10.1002/14651858.CD011272.pub3.

2

Comparison of the In Vitro and Ex Vivo Permeation of Existing Topical Formulations Used in the Treatment of Facial Angiofibroma and Characterization of the Variations Observed.用于治疗面部血管纤维瘤的现有局部用制剂的体外和离体渗透比较及所观察到的变化特征

Pharmaceutics. 2020 Nov 7;12(11):1060. doi: 10.3390/pharmaceutics12111060.